Foldamer helix bundle-based molecular encapsulation
US10233213B2 · kind B2 · utility
0Cited by
9References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 31, 2016 |
| Grant date | Mar 19, 2019 |
| Priority date | — |
| Expiry date | Aug 31, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08L75/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present description provides compositions and methods for producing therapeutic oligomeric compounds. In another aspect the description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the disclosure relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the disclosure may optionally be administered with at least one of a pharmaceutically acceptable excipient, additional pharmacologically active agent or a combination thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.